FRANCESCHETTI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.469
EU - Europa 657
AS - Asia 426
Totale 2.552
Nazione #
US - Stati Uniti d'America 1.460
DE - Germania 274
CN - Cina 227
UA - Ucraina 120
SG - Singapore 109
IT - Italia 72
TR - Turchia 71
RU - Federazione Russa 43
GB - Regno Unito 41
FI - Finlandia 36
SE - Svezia 25
PL - Polonia 18
FR - Francia 12
ID - Indonesia 9
CA - Canada 7
BE - Belgio 4
IN - India 4
NL - Olanda 4
VN - Vietnam 3
IR - Iran 2
LT - Lituania 2
MX - Messico 2
RO - Romania 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
LU - Lussemburgo 1
MY - Malesia 1
Totale 2.552
Città #
Chandler 195
Jacksonville 135
Fairfield 110
Woodbridge 109
Ashburn 104
Houston 96
Ann Arbor 93
Singapore 88
Santa Clara 78
Beijing 67
Izmir 45
Addison 40
Nanjing 40
Wilmington 39
Princeton 33
Cambridge 31
Seattle 31
San Diego 23
Milan 22
New York 22
Shanghai 21
Shenyang 18
Warsaw 18
Boardman 14
Los Angeles 14
Bremen 13
Hebei 12
Nanchang 11
Munich 10
Dearborn 9
Helsinki 9
Jakarta 9
Tianjin 9
Changsha 8
Washington 8
Jiaxing 6
San Mateo 6
Ferrara 5
London 5
Mountain View 5
Zhengzhou 5
Brussels 4
Kunming 4
Toronto 4
Dong Ket 3
Falls Church 3
Guangzhou 3
Indiana 3
Ningbo 3
Bollate 2
Brembate 2
Cattolica 2
Cuauhtémoc 2
Des Moines 2
Frankfurt am Main 2
Gualtieri 2
Haikou 2
Hefei 2
Jinan 2
Orange 2
Ottawa 2
Verona 2
Amsterdam 1
Arzano 1
Auburn Hills 1
Augusta 1
Bellante 1
Castelnuovo Rangone 1
Cavacurta 1
Costabissara 1
Dallas 1
Ercolano 1
Falkenstein 1
Ferrara di Monte Baldo 1
Fuzhou 1
Group 1
Hangzhou 1
Hounslow 1
Kalamazoo 1
Lappeenranta 1
Leawood 1
Luxembourg 1
Monmouth Junction 1
Mumbai 1
Norwalk 1
Olomouc 1
Pasadena 1
Philadelphia 1
Putian 1
Redwood City 1
San Francisco 1
Sandston 1
Selangor 1
Taizhou 1
Tappahannock 1
Trieste 1
Villa Cortese 1
Totale 1.704
Nome #
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 147
Growth hormone and skeletal muscle function 115
Evidence for androgen receptor gene expression in human thyroid cells and tumours 111
Retinoic acid-induced decrease of DNA synthesis and peroxidase mRNA levels in human thyroid cells expressing retinoic acid receptor alpha mRNA. 106
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 103
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 103
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 101
Diurnal rhythm of plasma catecholamines in acromegaly 99
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 98
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 96
Detection of androgen receptor (AR) mRNA by the reverse transcription polymerase chain reaction (RT-PCR) in human thyroids. 93
Effects of octreotide on gallbladder motor function in acromegaly 88
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 87
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 86
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 85
Sistema Simpatoadrenomidollare nei pazienti acromegalici 82
Efficacy, safety and adherence to treatment of teriparatide: an observational study 79
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 78
ASSE GH-IGF-I NELL'INVECCHIAMENTO 78
Human galanin reduces plasma norepinephrine levels in man 77
Expression of all-trans-retinoic acid receptor RNA in human thyroid cells. 74
Replacement therapy and quality of life improvement in adult GHD patients 74
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 73
Efficay and safety of teriparatide treatment 71
Bone metastases frequency, distribution, clinical and imaging characteristics in neuroendocrine tumors: our experience 69
Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope 65
Successful treatment with everolimus of functioning liver metastases from a pancreatic insulinoma 64
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids 40
Bone health in adolescence 38
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 37
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7) 34
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget 27
Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy 11
Totale 2.589
Categoria #
all - tutte 13.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.370
Totale 15.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020219 0 0 0 0 13 37 20 31 17 59 40 2
2020/2021248 26 12 11 25 9 32 5 30 7 30 47 14
2021/2022297 9 26 12 14 12 9 10 23 7 24 24 127
2022/2023373 35 50 3 60 43 59 19 30 42 4 16 12
2023/2024223 10 24 15 13 19 64 4 20 4 5 2 43
2024/2025260 27 18 64 39 112 0 0 0 0 0 0 0
Totale 2.589